Group 1 - Ark Health (06086.HK) experienced a significant drop, falling over 17% to reach HKD 3.12, with a current decline of 15.82% at the time of reporting [1][7]. - The company announced a placement of 45.181 million shares using a "old shares first, new shares later" method, which represents approximately 3.26% of the company's expanded issued share capital [3][9]. - The placement price is set at HKD 3.32 per share, reflecting a discount of about 11.94% compared to the previous closing price, with expected total proceeds of HKD 150 million and net proceeds of HKD 144 million [3][9]. Group 2 - Approximately 90% of the proceeds will be allocated to accelerate the development of the company's AI-driven chronic disease management platform, including model development and optimization, infrastructure and computing resource expansion, talent acquisition in AI and medical fields, data collection and annotation, knowledge base development, and the launch and promotion of AI-enhanced services to underserved patient and doctor groups [3][9]. - The remaining 10% of the funds will be used for working capital and general corporate purposes [3][9].
方舟健客跌超17% 公司宣布以先旧后新方式配售超4500万股